Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2020 Oct 22;29(12):2486–2494. doi: 10.1158/1055-9965.EPI-20-0223

Figure 1:

Figure 1:

Representation of the Barrett’s esophagus to esophageal adenocarcinoma progression sequence and accompanying genomic and epigenomic alterations. The alterations show are a representative, but not complete list of genes affected by mutation, amplification, or aberrant methylation. Those alterations shown to be candidate biomarkers are in bold text.